Tumor Pathway Activations Inhibited by Dovitinib
1 clinical trials · Condition
◉ Watch Tumor Pathway Activations Inhibited by Dovitinib
| Record | Firm | Date |
|---|---|---|
| Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib (NCT01831726) | Novartis Pharmaceuticals | 2013-08-01 |
Track Tumor Pathway Activations Inhibited by Dovitinib automatically
Every clearance here is in the API, with alerts when new ones post.